Bicara Therapeutics Inc <BCAX.O>: BMO initiates coverage with outperform rating; price target $35
BCAX•Related News
All In FutureTech Alliance announces virtual annual shareholder meeting
AIFA•
Parsons wins spot on Space Force NITE-STAR IDIQ with USD 981 million shared ceiling
PSN•
Movado Group sets conference call for Q2 fiscal 2027 results
MOV•
Caleres schedules Q2 2026 earnings release and conference call
CAL•
VisionWave UK names Tony Fabrizio director, aerospace and defense
VWAV•